Tchaikapharma High Quality Medicines AD (BUL:THQM)

BUL:THQM Revenue

Tchaikapharma High Quality Medicines AD had revenue of 9.52M EUR in the quarter ending June 30, 2026, with 17.47% growth. This brings the company's total for the last twelve months to 36.42M, up 21.98% year-over-year. In the year 2025, Tchaikapharma High Quality Medicines AD had annual revenue of 32.74M with 20.17% growth. That makes Tchaikapharma High Quality Medicines AD the 29,360th largest company in the world by revenue and 39th in Bulgaria.

• Revenue (ttm): 36.42M
• Revenue Growth: +21.98%
• P/S Ratio: 24.48
• Revenue / Employee: 171.79K
• Employees: 214
• Market Cap: 891.44M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Bulgaria 31.76M 97.2%
• European Union 711.54K 2.2%
• Exports 214.84K 0.7%

Fiscal year ended Dec 31, 2025 See the full BUL:THQM breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	32.74M	5.50M	20.17%
Dec 31, 2024	27.24M	2.44M	9.83%
Dec 31, 2023	24.80M	2.75M	12.46%
Dec 31, 2022	22.06M	357.10K	1.65%
Dec 31, 2021	21.70M	1.20M	5.84%

Data Source: S&P Global Market Intelligence Last updated: Jul 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error